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Oxidative damage from elevated production of reactive
oxygen species (ROS) contributes to ischemia-reperfusion
injury (IRI) in many pathologies, such as myocardial
infarction, stroke, and organ transplantation. We recently
determined a critical mechanism for protection from IRI
by nitric oxide (NO)-dependent S-nitrosation using a
mitochondria-selective S-nitrosating agent, MitoSNO.
MitoSNO contains an S-nitrosating moiety derived from
the NO-donor SNAP, attached to a lipophilic triphenyl-
phosphonium cation that leads to its rapid and extensive
uptake within mitochondria in vivo. Protection by
MitoSNO is afforded by inhibition of complex I through
selective S-nitrosation of Cys39 on the ND3 subunit,
which becomes susceptible to modification only after
ischaemia. The observed posttranslational alteration of
complex I slows the reactivation of mitochondria during
the crucial first minutes of the reperfusion of ischemic tis-
sue, thereby decreasing ROS production, oxidative damage
and tissue necrosis.
Furthermore, we could show that the reperfusion-
induced ROS production is not an unspecific event of
complex I reactivation but is highly regulated by a dra-
matic increase in succinate during ischaemia. ROS are
subsequently produced via reverse electron transport and
inhibition of the succinate rise during ischaemia proved to
be a further promising target to protect against IRI injury.
Taken together, reversible S-nitrosation of complex I or
the prevention of ischaemic succinate accumulation
results in significant protection from acute and long-term
effects of IRI and provide evidence for compounds selec-
tively targeting the mitochondria, such as MitoSNO, to be
a promising therapeutic strategy for translation to use in
humans.
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